Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?

被引:11
|
作者
Melero Cortes, Lidia Maria [1 ]
Martinez Maestre, M. Angeles [1 ]
Vieites Perez-Quintela, M. Begona [2 ]
Gambadauro, Pietro [3 ,4 ]
机构
[1] Virgen del Rocio Univ Hosp, Gynecol Div, C Manuel Siurot S-N, Seville, Spain
[2] Virgen del Rocio Univ Hosp, Pathol Dept, Seville, Spain
[3] Uppsala Univ Hosp, Ctr Reprod, Uppsala, Sweden
[4] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden
关键词
Ovarian tumours; Sertoli-Leydig cell tumour; gynaecological endocrinology; hyperandrogenism; abnormal uterine bleeding; fertility preservation; OF-THE-LITERATURE; CLINICOPATHOLOGICAL ANALYSIS; MANAGEMENT;
D O I
10.1080/01443615.2017.1291590
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian Sertoli-Leydig cell tumours (OSLCT) are rare and typically present with androgenic manifestations in women of the 2nd-3rd decade. Out of 228 diagnoses of ovarian sex cord-stromal tumours recorded at an academic institution during a 14-year period, eight women were surgically treated for OSLCT. Patient mean age was 54.8years (range 19-81), five women being in the postmenopausal stage (62.5%). Only one woman presented with androgenic manifestations (12.5%), four with abnormal/postmenopausal uterine bleeding (50%), and three with abdominal pain (37.5%). Fertility sparing or radical surgery was performed depending on patient age and stage of disease. The only patient with an advanced disease (FIGO stage IV) was referred to palliative care postoperatively. The other seven were at FIGO stage I. Five of them were free from disease at a mean follow-up of 67months, while the remaining two were lost at follow-up. The youngest woman of the series, treated with fertility-preserving unilateral salpingo-oophorectomy at the age of 19, had two spontaneous pregnancies and deliveries of healthy babies during a 10-year follow-up period. In conclusion, our single institution 14-year experience demonstrates that the diagnosis of OSLCT is particularly challenging since many patients are older than expected and lack androgenic manifestations. Impact statement center dot What is already known on this subjectOvarian Sertoli-Leydig cell tumours (OSLCT) are rare and are thought to typically present with androgenic manifestations in women of the 2nd-3rd decade.center dot What the results of this study addOur single institution 14-year experience shows that a high proportion of women with ovarian Sertoli-Leydig cell tumours may not present with androgenic manifestations, and many of them also are in the postmenopausal stage. Most patients have a good prognosis and fertility-preserving surgery in younger women can lead to spontaneous pregnancies and deliveries of healthy children after treatment.center dot What are the implications of these findings for clinical practice and/or further researchThe diagnosis of OSLCT is particularly challenging and therefore not reached before surgery in most of the cases. However, while hysterectomy with bilateral salpingo-oophorectomy and surgical staging are recommended for women with higher stage or no fertility wish, fertility-sparing surgery should be considered in younger women with early disease. Therefore, further research should focus on non-invasive diagnosis possibly by means of laboratory or imaging techniques.
引用
收藏
页码:655 / 659
页数:5
相关论文
共 50 条
  • [41] Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries
    Nelson, Alexander T.
    Harris, Anne K.
    Watson, Dave
    Kamihara, Junne
    Chen, Kenneth S.
    Stall, Jennifer N.
    Devins, Kyle M.
    Young, Robert H.
    Olson, Damon R.
    Mallinger, Paige H. R.
    Mitchell, Sarah G.
    Hoffman, Lindsey M.
    Halliday, Gail
    Suleymanova, Amina M.
    Bender, Julia L. Glade
    Messinger, Yoav H.
    Herzog, Cynthia E.
    Field, Amanda L.
    Frazier, A. Lindsay
    Stewart, Douglas R.
    Dehner, Louis P.
    Hill, D. Ashley
    Billmire, Deborah F.
    Schneider, Dominik T.
    Schultz, Kris Ann P.
    GYNECOLOGIC ONCOLOGY, 2024, 186 : 117 - 125
  • [42] Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl
    Bhardwaj, Swati
    Banet, Natalie
    Gaston, Emily C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (02) : 140 - 144
  • [43] A case of Sertoli-Leydig cell tumour of the ovary with a multilocular cystic appearance on CT and MR imaging
    Azuma, Asako
    Koyama, Takashi
    Mikami, Yoshiki
    Tamai, Ken
    Fujimoto, Koji
    Morisawa, Nobuko
    Nagano, Fusaka
    Yoshioka, Shinya
    Togashi, Kaori
    PEDIATRIC RADIOLOGY, 2008, 38 (08) : 898 - 901
  • [44] Recurrence of Sertoli-Leydig cell tumour in contralateral ovary. Case report and review of literature
    Latthe, P
    Shafi, MI
    Rollason, TP
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (01) : 62 - 63
  • [45] A case of Sertoli-Leydig cell tumour of the ovary with a multilocular cystic appearance on CT and MR imaging
    Asako Azuma
    Takashi Koyama
    Yoshiki Mikami
    Ken Tamai
    Koji Fujimoto
    Nobuko Morisawa
    Fusaka Nagano
    Shinya Yoshioka
    Kaori Togashi
    Pediatric Radiology, 2008, 38 : 898 - 901
  • [46] Sertoli-Leydig cell tumor characterized by hyperestrogenism in a postmenopausal woman: a case report and review of the literature
    Wang, L.
    Yao, A.
    Zhang, A.
    Qu, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (03) : 502 - 505
  • [47] Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell turnours
    Lenhard, Miriam
    Kuemper, Caroline
    Ditsch, Nina
    Diebold, Joachim
    Stieber, Petra
    Friese, Klaus
    Burges, Alexander
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (05) : 657 - 661
  • [48] Severe intrahepatic cholestasis of pregnancy due to a Sertoli-Leydig cell tumour in a woman with polycystic ovary syndrome: a case report
    Yun, Feng
    Fu, Leyi
    Xu, Dong
    Qu, Fan
    Wang, Fangfang
    BMC PREGNANCY AND CHILDBIRTH, 2022, 22 (01)
  • [49] Sertoli Leydig Cell Tumour Initially Misdiagnosed as Polycystic Ovarian Syndrome and Congenital Adrenal Hyperplasia: A Case Report
    Paudyal, Pooja
    Gurung, Geeta
    Baral, Josie
    Kharel, Nisha
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2020, 58 (231) : 923 - 926
  • [50] OVARIAN SERTOLI-LEYDIG CELL TUMOUR WITH α-FETOPROTEIN- PRODUCING INTESTINAL GLANDULAR CELLS. CLINICAL CASE AND SHORT REVIEW OF BASIC LITERATURE
    Strus, Michal
    Rajtar-Ciosek, Agnieszka
    Jach, Robert
    Hankus, Jerzy
    Szczepanski, Wojciech
    POLISH JOURNAL OF PATHOLOGY, 2019, 70 (03) : 226 - 231